News
SIGA
3.000
+4.17%
0.120
Weekly Report: what happened at SIGA last week (0803-0807)?
Weekly Report · 5d ago
U.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated
Benzinga · 08/07 15:06
SIGA Technologies GAAP EPS of $0.17, revenue of $41M
Seeking Alpha · 08/06 20:03
SIGA Technologies Q2 EPS $0.17 Down From $0.49 YoY, Sales $41.002M Down From $81.120M YoY
Benzinga · 08/06 20:02
Press Release: SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026
Dow Jones · 08/06 20:01
Press Release: SIGA Reports Financial Results for -2-
Dow Jones · 08/06 20:01
Weekly Report: what happened at SIGA last week (0727-0731)?
Weekly Report · 08/03 09:15
Siga Technologies: Q2 Earnings Due, New TPOXX Orders A Must
Seeking Alpha · 07/28 17:28
Weekly Report: what happened at SIGA last week (0720-0724)?
Weekly Report · 07/27 09:16
Weekly Report: what happened at SIGA last week (0713-0717)?
Weekly Report · 07/20 09:16
Weekly Report: what happened at SIGA last week (0706-0710)?
Weekly Report · 07/13 09:16
Weekly Report: what happened at SIGA last week (0629-0703)?
Weekly Report · 07/06 09:17
Weekly Report: what happened at SIGA last week (0622-0626)?
Weekly Report · 06/29 09:16
Weekly Report: what happened at SIGA last week (0615-0619)?
Weekly Report · 06/22 09:18
Weekly Report: what happened at SIGA last week (0608-0612)?
Weekly Report · 06/15 09:17
SIGA Technologies Shareholders Approve Directors and Equity Plan
TipRanks · 06/10 20:59
Weekly Report: what happened at SIGA last week (0601-0605)?
Weekly Report · 06/08 09:17
Weekly Report: what happened at SIGA last week (0525-0529)?
Weekly Report · 06/01 09:18
Weekly Report: what happened at SIGA last week (0518-0522)?
Weekly Report · 05/25 09:18
Siga Technologies Balances Lumpy Results With Strong Cash
TipRanks · 05/20 03:34
More
Webull provides a variety of real-time SIGA stock news. You can receive the latest news about Siga Technologie through multiple platforms. This information may help you make smarter investment decisions.
About SIGA
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.